EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High-Sensitivity Cardiac Troponin T to Exclude Cardiac Involvement in TTR Variant Carriers and ATTRv Amyloidosis Patients

Hendrea S A Tingen, Milou Berends iD, Alwin Tubben iD, Johan Bijzet iD, Ewout J Houwerzijl, Friso L H Muntinghe, Bart-Jan Kroesen, Paul A van der Zwaag, Peter van der Meer, Riemer H J A Slart iD, Bouke P C Hazenberg iD, Hans L A Nienhuis iD

Journal of Clinical Medicine · 30.01.2024 · 13 (3) · 810

DOI: 10.3390/jcm13030810 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 30.01.2024. Verfasst von Hendrea S A Tingen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine and Molecular Imaging, Groningen Amyloidosis Centre of Expertise, University of Groningen, University Medical Centre G…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

Individuals carrying a pathogenic transthyretin gene variant (TTRv) are at high risk for developing hereditary transthyretin (ATTRv) amyloidosis and are routinely screened for the development of cardiomyopathy (ATTRv-CM). This study aims to evaluate whether the cardiac biomarkers N-terminal pro B-type natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin T (hs-cTnT) can be used to rule out ATTRv-CM. (2)

Methods

In this retrospective case-control study, data from 46 ATTRv-CM patients and 101 TTRv carriers and ATTRv amyloidosis patients without cardiomyopathy were included. Binary logistic regression models were used to assess the ability of NT-proBNP and hs-cTnT to predict the diagnosis of ATTRv-CM. An optimal cutoff for the relevant biomarker(s) was determined based on a sensitivity of ≥99% and the highest possible percentage of additional tests avoided (%ATA) in the index dataset. (3)

Results

Hs-cTnT demonstrated the highest predictive capabilities for ATTRv-CM. The addition of NT-proBNP did not improve the predictive model. A hs-cTnT cutoff of

Schlagwörter

Stichwörter der Autor:innen

ATTRvN-terminal pro B-type natriuretic peptideamyloidosisbiomarkersbone scintigraphycardiaccardiomyopathycarriershigh-sensitivity cardiac troponin Ttransthyretin

Autor:innen und Institutionen

  • Department of Nuclear Medicine and Molecular Imaging, Groningen Amyloidosis Centre of Expertise, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
  • Department of Internal Medicine, Groningen Amyloidosis Centre of Expertise, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
  • Department of Cardiology, Groningen Amyloidosis Centre of Expertise, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
  • Department of Laboratory Medicine, Groningen Amyloidosis Centre of Expertise, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
  • Department of Genetics, Groningen Amyloidosis Centre of Expertise, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
  • Biomedical Photonic Imaging Group, Faculty of Science and Technology, University of Twente, Drienerlolaan 5, 7522 NB Enschede, The Netherlands.

ORCID-Profile: Milou Berends, Alwin Tubben, Johan Bijzet, Riemer H J A Slart, Bouke P C Hazenberg, Hans L A Nienhuis

Zitieren

APA

Tingen, H. S. A., Berends, M., Tubben, A., Bijzet, J., Houwerzijl, E. J., Muntinghe, F. L. H., Kroesen, B. J., van der Zwaag, P. A., van der Meer, P., Slart, R. H. J. A., Hazenberg, B. P. C., & Nienhuis, H. L. A. (2024). High-Sensitivity Cardiac Troponin T to Exclude Cardiac Involvement in TTR Variant Carriers and ATTRv Amyloidosis Patients. Journal of Clinical Medicine, 13(3), 810. https://doi.org/10.3390/jcm13030810

Vancouver

Tingen HSA, Berends M, Tubben A, Bijzet J, Houwerzijl EJ, Muntinghe FLH, et al. High-Sensitivity Cardiac Troponin T to Exclude Cardiac Involvement in TTR Variant Carriers and ATTRv Amyloidosis Patients. Journal of Clinical Medicine. 2024;13(3):810. doi:10.3390/jcm13030810

BibTeX
@article{Tingen2024,
  author = {Tingen, Hendrea S A and Berends, Milou and Tubben, Alwin and Bijzet, Johan and Houwerzijl, Ewout J and Muntinghe, Friso L H and Kroesen, Bart-Jan and van der Zwaag, Paul A and van der Meer, Peter and Slart, Riemer H J A and Hazenberg, Bouke P C and Nienhuis, Hans L A},
  title = {High-Sensitivity Cardiac Troponin T to Exclude Cardiac Involvement in TTR Variant Carriers and ATTRv Amyloidosis Patients},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {3},
  pages = {810},
  doi = {10.3390/jcm13030810}
}
Kostenlos starten →